GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » SunWay Biotech Co Ltd (ROCO:1271) » Definitions » EV-to-EBITDA

SunWay Biotech Co (ROCO:1271) EV-to-EBITDA : 74.01 (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is SunWay Biotech Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SunWay Biotech Co's enterprise value is NT$6,177.2 Mil. SunWay Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$83.5 Mil. Therefore, SunWay Biotech Co's EV-to-EBITDA for today is 74.01.

The historical rank and industry rank for SunWay Biotech Co's EV-to-EBITDA or its related term are showing as below:

ROCO:1271' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.77   Med: 11.61   Max: 75.43
Current: 74

During the past 5 years, the highest EV-to-EBITDA of SunWay Biotech Co was 75.43. The lowest was 6.77. And the median was 11.61.

ROCO:1271's EV-to-EBITDA is ranked worse than
96.16% of 1561 companies
in the Consumer Packaged Goods industry
Industry Median: 10.77 vs ROCO:1271: 74.00

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), SunWay Biotech Co's stock price is NT$105.00. SunWay Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.460. Therefore, SunWay Biotech Co's PE Ratio for today is 71.92.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


SunWay Biotech Co EV-to-EBITDA Historical Data

The historical data trend for SunWay Biotech Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SunWay Biotech Co EV-to-EBITDA Chart

SunWay Biotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - 9.04 31.86 93.61

SunWay Biotech Co Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.04 - 31.86 - 93.61

Competitive Comparison of SunWay Biotech Co's EV-to-EBITDA

For the Packaged Foods subindustry, SunWay Biotech Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SunWay Biotech Co's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, SunWay Biotech Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SunWay Biotech Co's EV-to-EBITDA falls into.



SunWay Biotech Co EV-to-EBITDA Calculation

SunWay Biotech Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6177.204/83.467
=74.01

SunWay Biotech Co's current Enterprise Value is NT$6,177.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SunWay Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$83.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SunWay Biotech Co  (ROCO:1271) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

SunWay Biotech Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=105.00/1.460
=71.92

SunWay Biotech Co's share price for today is NT$105.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SunWay Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


SunWay Biotech Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SunWay Biotech Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SunWay Biotech Co (ROCO:1271) Business Description

Traded in Other Exchanges
N/A
Address
No. 139, Xing’ai Road, Neihu District, Taipei, TWN, 11494
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.

SunWay Biotech Co (ROCO:1271) Headlines

No Headlines